Pharmacology of a new antidepressant: benefit of the implication of the melatonergic system.

@article{Fuchs2006PharmacologyOA,
  title={Pharmacology of a new antidepressant: benefit of the implication of the melatonergic system.},
  author={Eberhard Fuchs and Maria Dolores Sim{\'o}n and Barthel Schmelting},
  journal={International clinical psychopharmacology},
  year={2006},
  volume={21 Suppl 1},
  pages={S17-20}
}
The limitations of current antidepressant medications merit the exploration of alternative agents with novel antidepressant mechanisms of action. The established clinical finding that desynchronization of internal rhythms plays an important role in the pathophysiology of depressive disorders has stimulated the idea that resetting normal circadian rhythms may have antidepressant potential. Recent experiments using the novel melatonin receptor agonist and serotonin 2 (5-HT2c) receptor antagonist… CONTINUE READING
22 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 22 extracted citations

Similar Papers

Loading similar papers…